Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 4:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1537–1560 of 3,914 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hypertension Clear all

Conditions: Hypertension
Interventions: Spinal Manipulation, Sham Spinal Manipulation; Other
Lead sponsor: Palmer College of Chiropractic; Other
Eligibility: 21 Years to 75 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Davenport, Iowa

Conditions: Hypertension
Interventions: Yoga session; Behavioral
Lead sponsor: Texas State University; Other
Eligibility: 20 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Marcos, Texas

Conditions: Hypertension, Diabetes, Dyslipidemia
Interventions: Medication Adherence Smartphone App; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 3
States / cities: Little Rock, Arkansas

Conditions: Pulmonary Hypertension
Interventions: iNO, Non-invasive nitric oxide; Drug · Procedure
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetes, Hypertension, Insulin Resistance
Interventions: The DASH diet with weight loss, The DASH diet without weight loss, Dairy diet; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Glaucoma, Vision Disorder
Interventions: Virtual Reality Stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 12 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Hypertension
Interventions: Intervention, Active Comparator; Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Gestational Hypertension
Interventions: Intervention is blood pressure management approach.; Procedure
Lead sponsor: University of British Columbia; Other
Eligibility: Female only
Enrollment: 987 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 11
States / cities: New Haven, Connecticut • Louisville, Kentucky • Boston, Massachusetts + 7 more

Conditions: Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: Pulmonary Hypertension Association, Inc.; Other
Eligibility: 0 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2025
U.S. locations: 52
States / cities: Phoenix, Arizona • Sacramento, California • San Francisco, California + 40 more

Conditions: Pulmonary Arterial Hypertension
Interventions: sapropterin dihydrochloride (6R-BH4); Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Hypertension, Pulmonary
Interventions: ambrisentan, tadalafil; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 61
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 50 more

Conditions: Hypertension, Living Kidney Donor, Dietary Sodium Intake
Interventions: Dietary sodium; Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Orange, California

Conditions: Hypertension
Interventions: Irbesartan and Hydrochlorothiazide, Avalide; Drug
Lead sponsor: Roxane Laboratories; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Hypertension, Systolic
Interventions: Zona Plus Device, Control Device; Device
Lead sponsor: Zona Health, Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 5
States / cities: St Louis, Missouri • Charlotte, North Carolina • Goldsboro, North Carolina + 2 more

Conditions: Hypertension, Non-Adherence, Patient
Interventions: Wellth Smartphone App, Targeted Incentives, Non-Restricted Incentives; Behavioral
Lead sponsor: Wellth Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: San Diego, California • New York, New York

Conditions: Hypertension
Interventions: metoprolol succinate; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 30
States / cities: Little Rock, Arkansas • Bellflower, California • Beverly Hills, California + 27 more

Conditions: Pulmonary Arterial Hypertension
Interventions: Pulmonary Arterial Hypertension - Lung Perfusion Scans; Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease
Interventions: Ralinepag; Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 48
States / cities: Phoenix, Arizona • Tucson, Arizona • La Jolla, California + 38 more

Conditions: Open Angle Glaucoma
Interventions: Nasal 180° Selective Laser Trabeculoplasty (SLT), Inferior 180° Selective Laser Trabeculoplasty (SLT); Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Preeclampsia, Hypotension
Interventions: Ephedrine, Phenylephrine; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2016
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Glaucoma
Interventions: AI-based glaucoma screening, IOP measurement, Virtual Reality Visual Field Testing; Device
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 40 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 7
States / cities: Boston, Massachusetts • Chelsea, Massachusetts • Lynn, Massachusetts + 2 more

Conditions: Hypertension
Interventions: Electronic personal health record; Other
Lead sponsor: Augusta University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 445 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Hypertension
Interventions: Health Literacy-focused Self-help, Delayed Intervention Control; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Psychological Stress, Hypertension, Renal
Interventions: mycophenolate mofetil (MMF), Placebo; Drug
Lead sponsor: Augusta University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Augusta, Georgia

Search by objective public record fields.

Chiropractic for Hypertension in Patients

Acute Effects of Vinyasa Yoga on Vascular Function

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn

The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)

Virtual Reality for Enhancement of Vision

Enhancing Systems of Care to Improve Hypertension Guideline Implementation

The CHIPS Trial (Control of Hypertension In Pregnancy Study)

Pulmonary Hypertension Association Registry

6R-BH4 Pulmonary Arterial Hypertension Study

A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Dietary Sodium Intake and Blood Pressure in Living Kidney Donors

Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

A Pivotal Study To Evaluate The Effectiveness of Isometric Handgrip Therapy In Prehypertensive And Hypertensive Patients

Telehealth Intervention for Improved Blood Pressure Control With Targeted Incentives

307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects

Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree

Phenylephrine in Spinal Anesthesia in Preeclamptic Patients

The Glaucoma and Retinopathy Screening Study

Using an Electronic Personal Health Record to Empower Patients With Hypertension

Understanding Health Care Information for African Americans With High Blood Pressure

Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress